Shalini Verma, MD, FCAP

Laboratory and Medical Director

Dr. Verma serves as Laboratory Director and Medical Director for PierianDx molecular diagnostics clinical laboratory. 

Dr. Verma is a diplomate of the American Board of Pathology with board certifications in Molecular Genetic Pathology, Hematopathology and Anatomic & Clinical Pathology. She completed her fellowships and residency training at the University of Texas MD Anderson Cancer Center, Houston, Weill Cornell Medical College/New York Presbyterian Hospital, New York and the Los Angeles County/University of Southern California Medical Center, Los Angeles. Dr. Verma received her M.D. degree from the J.J.M.. Medical College, India.  

Dr. Verma has served as Senior Medical Director and Clinical Laboratory Director at various large clinical laboratories and diagnostic companies including GE-Clarient Diagnostic Services, Roche Molecular Systems and Roche Sequencing Services.  In her role, she was responsible for providing medical oversight to the molecular diagnostic services in Clinical and the Biopharma laboratory. She worked closely with the R&D and commercial teams to develop and better align the company’s molecular services with the market needs.

Dr. Verma continues to pursue independent and collaborative research in Hematopathology and Molecular Genetic Pathology. Her work has been published in prominent peer-reviewed scientific journals and has also been selected for presentation at various national and international forums. She actively participates in various committees with professional organizations like the College of American Pathology and the Association of Molecular Pathology.

Shalini Verma, MD, FCAP